Description
| Item ID # | 19388910 |
| Manufacturer # | 1938406 |
| Brand | |
Corticosteroid Dexamethasone Sodium Phosphate 10 mg / mL Injection Vial 10 mL
UOM CARTON/10
$166.62
10000 in stock
Related products
-
#64968909 Mfr#Zostavax® Shingles Vaccine Varicella – Zoster Virus Vaccine, Live, Attenuated. Preservative Free 19400 Unit / 0.65 mL Injection Single Dose Vial 0.65 mL
Features
- ZOSTAVAX* is supplied as follows: (1) a package of 10 single-dose vials of lyophilized vaccine, NDC 0006-4963-41 (package A); and (2) a separate package of 10 vials of diluent (package B)
- ZOSTAVAX* is stored frozen and should be reconstituted immediately upon removal from the freezer
- The diluent should be stored separately at room temperature (20 to 25 degrees celcius, 68 to 77 degrees fahrenheit), or in the refrigerator (2 to 8 degrees celcius, 36 to 46 degrees fahrenheit)
-
#93858910 Mfr# H93850Top Fill Bag 1500 mL, PVC
Features
- Source container for pump tube sets
- With reclosable wide-mouth opening
- This product is required to be reported under California Proposition 65
-
#49638909 Mfr#Zostavax® Shingles Vaccine Varicella – Zoster Virus Vaccine, Live, Attenuated. Preservative Free 19400 Unit / 0.65 mL Injection Single Dose Vial 0.65 mL
Features
- ZOSTAVAX is supplied as follows: (1) a package of 1 single-dose vial of lyophilized vaccine, NDC 0006-4963-00 (package A); and (2) a separate package of 10 vials of diluent (package B)
- ZOSTAVAX* is stored frozen and should be reconstituted immediately upon removal from the freezer
- The diluent should be stored separately at room temperature (20 to 25 degrees celcius, 68 to 77 degrees fahrenheit), or in the refrigerator (2 to 8 degrees celcius, 36 to 46 degrees fahrenheit)
-
#58908900 Mfr# 589-05Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart